Bacterial 30S ribosomal 16S rRNA aminoacyl-tRNA site (A-site) (16S rRNA A-site)

The bacterial 30S ribosomal 16S rRNA A-site is a highly conserved region within the small ribosomal subunit that plays a fundamental role in the decoding of messenger RNA (mRNA) during protein synthesis [1, 2]. It specifically facilitates the selection of the correct aminoacyl-tRNA by monitoring the base-pairing between the mRNA codon and the tRNA anticodon [2, 4]. Key nucleotides, such as A1492 and A1493, undergo conformational flipping to stabilize cognate tRNA binding, a process essential for translation fidelity [2]. This site is the primary therapeutic target for aminoglycoside antibiotics, which bind to the A-site and lock it in a state that mimics correct decoding, leading to the incorporation of incorrect amino acids and bacterial cell death [1, 3]. Tetracyclines also target this region by sterically hindering the entry of aminoacyl-tRNAs, thereby halting protein elongation [1]. Despite their clinical utility against diverse bacterial infections, drugs targeting the 16S rRNA A-site are associated with serious adverse effects, including permanent ototoxicity and reversible nephrotoxicity [3, 5]. These toxicities often arise from the structural similarity between bacterial 16S rRNA and human mitochondrial 12S rRNA, leading to off-target inhibition of mitochondrial protein synthesis [5].

Other names

Decoding centerAminoacyl-tRNA binding site30S A-site16S rRNA decoding site

Aminoglycosides bind to the 16S rRNA A-site, inducing a conformational change in nucleotides A1492 and A1493 that mimics the cognate tRNA-mRNA interaction, leading to misreading of the genetic code and mistranslation [1, 3]. Tetracyclines bind to the same site to sterically block the docking of aminoacyl-tRNA, thereby inhibiting protein elongation [1].